A transcriptomic profile investigation followed by immunohistochemistry validation has identified the allograft inflammatory factor 1 (AIF1) gene as an unfavorable prognostic factor in this carcinoma and demonstrated that it is associated with immune infiltrates (160). The gene discussed is AIF1; the disease is carcinoma.